» Articles » PMID: 23589723

Activation of AMP-Activated Protein Kinase α and Extracelluar Signal-Regulated Kinase Mediates CB-PIC-Induced Apoptosis in Hypoxic SW620 Colorectal Cancer Cells

Overview
Date 2013 Apr 17
PMID 23589723
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Here, antitumor mechanism of cinnamaldehyde derivative CB-PIC was elucidated in human SW620 colon cancer cells. CB-PIC significantly exerted cytotoxicity, increased sub-G1 accumulation, and cleaved PARP with apoptotic features, while it enhanced the phosphorylation of AMPK alpha and ACC as well as activated the ERK in hypoxic SW620 cells. Furthermore, CB-PIC suppressed the expression of HIF1 alpha, Akt, and mTOR and activated the AMPK phosphorylation in hypoxic SW620 cells. Conversely, silencing of AMPK α blocked PARP cleavage and ERK activation induced by CB-PIC, while ERK inhibitor PD 98059 attenuated the phosphorylation of AMPK α in hypoxic SW620 cells, implying cross-talk between ERK and AMPK α . Furthermore, cotreatment of CB-PIC and metformin enhanced the inhibition of HIF1 α and Akt/mTOR and the activation of AMPK α and pACC in hypoxic SW620 cells. In addition, CB-PIC suppressed the growth of SW620 cells inoculated in BALB/c athymic nude mice, and immunohistochemistry revealed that CB-PIC treatment attenuated the expression of Ki-67, CD34, and CAIX and increased the expression of pAMPK α in CB-PIC-treated group. Interestingly, CP-PIC showed better antitumor activity in SW620 colon cancer cells under hypoxia than under normoxia, since it may be applied to chemoresistance. Overall, our findings suggest that activation of AMPK α and ERK mediates CB-PIC-induced apoptosis in hypoxic SW620 colon cancer cells.

Citing Articles

Cinnamaldehyde: Pharmacokinetics, anticancer properties and therapeutic potential (Review).

Han R, Li X, Gao X, Lv G Mol Med Rep. 2024; 30(3).

PMID: 38994757 PMC: 11267250. DOI: 10.3892/mmr.2024.13287.


RETRACTED: Adenine Combined with Cisplatin Promotes Anticancer Activity against Hepatocellular Cancer Cells through AMPK-Mediated p53/p21 and p38 MAPK Cascades.

Huang J, Lin Y, Chen H, Lin J, Kao S Pharmaceuticals (Basel). 2022; 15(7).

PMID: 35890094 PMC: 9322617. DOI: 10.3390/ph15070795.


The Antitumor Effect of Cinnamaldehyde Derivative CB-PIC in Hepatocellular Carcinoma Cells via Inhibition of Pyruvate and STAT3 Signaling.

Kim H, Lee H, Sim D, Park J, Ahn C, Park S Int J Mol Sci. 2022; 23(12).

PMID: 35742904 PMC: 9223629. DOI: 10.3390/ijms23126461.


Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity.

Singh M, Nicol A, DelPozzo J, Wei J, Singh M, Nguyen T Front Cardiovasc Med. 2022; 9:839644.

PMID: 35141304 PMC: 8818847. DOI: 10.3389/fcvm.2022.839644.


Adenine Inhibits the Invasive Potential of DLD-1 Human Colorectal Cancer Cell via the AMPK/FAK Axis.

Huang C, Lin Y, Hung C, Chen H, Lin J, Wang C Pharmaceuticals (Basel). 2021; 14(9).

PMID: 34577560 PMC: 8469022. DOI: 10.3390/ph14090860.


References
1.
Doublier S, Belisario D, Polimeni M, Annaratone L, Riganti C, Allia E . HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast. BMC Cancer. 2012; 12:4. PMC: 3262753. DOI: 10.1186/1471-2407-12-4. View

2.
Wang W, Guan K . AMP-activated protein kinase and cancer. Acta Physiol (Oxf). 2009; 196(1):55-63. DOI: 10.1111/j.1748-1716.2009.01980.x. View

3.
Jeong H, Han D, Son K, Han M, Lim J, Ha J . Antitumor effect of the cinnamaldehyde derivative CB403 through the arrest of cell cycle progression in the G2/M phase. Biochem Pharmacol. 2003; 65(8):1343-50. DOI: 10.1016/s0006-2952(03)00038-8. View

4.
Lu Z, Xu S . ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life. 2006; 58(11):621-31. DOI: 10.1080/15216540600957438. View

5.
Roberts P, Der C . Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007; 26(22):3291-310. DOI: 10.1038/sj.onc.1210422. View